Pyongyang, November 23 (KCNA) — A new antiphlogistic and analgesic medicine Neoselen was made in the DPRK for the first time recently.
According to information available from a researcher of Pyongyang University of Medicine Yu Sun Chol, the medicine was designed on the basis of the theoretical study of the restraint course of Cyclo-Oxygenase, common influence of the Non-Steroidal Anti-Inflammatory Drugs, with the help of a computer.
The medicine is new organic selenium of which synthesis is simple and its high pharmacological activation is expected.
Yu Sun Chol proved objectivity of the design through pharmacological experiments and clinical examinations and completed standardization of medicines by new substance, the first of its kind in the DPRK.
Neoselen’s pharmacological activation is 30-100 times that of aspirin and over 3-10 times Indometacin or Piroxicam well known to the world. Its efficacy is 25 times that of aspirin and 2.5 times Indometacin.
This medicine can be taken for a long time as it has no side effect such as stomach trouble commonly caused by the existing medicines and is very less toxic.
This is good for the treatment of various inflammation diseases such as rheumatic arthritis, toothache and other aches, fever and so on.
Simple in its manufacturing process and high in its actual extraction rate, this medicine can be made not only at large pharmaceutical factories but at minor ones and hospitals.
Image credit: https://www.flickr.com/photos/sheridansofasia/6043902264/